Get started

Catalyst

Symmetrical Triangle BreakoutEYPT chart is building up for another run. Potential catalyst before year end with an sNDA for Short Duration Yutiq. accumulation has been slow and steady indicating EYPT oversold conditions. Technical's: weekly chart --> Harmonic Gartley (bounced off significant support level) and been in uptrend since. Symmetrical Triangle/ Breakout setup has been known to act as a pre-courser to huge upside moves (40%+). Bull flag building in the symmetrical triangle. . . Read the rest then check out the rest of our trade ideas HERE Disclosure: I am long EYPT. I am not a financial advisor and this is not a buy/ sell recommendation but for education purposes only. Please do your homework before investing.
NASDAQ:EYPTLong
by follow_the_money
99.9% down from ATH. A play for biotech catalyst investorsRegenerative medicine company developing novel placenta-based cell therapy products. The Company has reported robust clinical trial data in multiple indications for its patented PLX cell product candidates and is currently conducting late stage clinical trials in several indications. PLX cell product candidates are believed to release a range of therapeutic proteins in response to inflammation, ischemia, muscle trauma, hematological disorders and radiation damage. The cells are grown using the Company's proprietary three-dimensional expansion technology and can be administered to patients off-the-shelf, without tissue matching. Pluristem has a strong intellectual property position; a Company-owned and operated GMP-certified manufacturing and research facility; strategic relationships with major research institutions; and a seasoned management team.
P
by warrenhochfeld
1
Soliton $SOLY Will Likely Trail Down Until Next CatalystSoliton reported highly anticipated results from its study on cellulite reduction on Monday, July 15th. In anticipation, the stock ran from $12 to $20, but on the day of, the stock closed down 15%. Soliton is a small cap medical device company that has an acoustic shockwave technology for tattoo removal called Rapid Acoustic Pulse (RAP). The treatment works pretty well, needing only 2-3 visits to remove tattoos vs the standard of care (lasers) which take about 10 doctor visits. They have also put a lot of press out about the potential of using their device for cellulite. It's worth nothing that this was their second cellulite trial. The company presented their first trial results using RAP to treat cellulite on May 11 at the National Aesthetics Conference. They also went on Yahoo Finance Video to talk about the results. The trial "succeeded" said management, however, the stock responded less than enthusiastically. The Full Article Is At BehindTheBid.com (CLICK HERE)
SShort
by behindthebid
3
Catalyst investing with T2 Biosystems (TTOO)Shares of T2 Biosystems (TTOO) have fallen by roughly 75% since the company's IPO was priced at $11 in 2014. Over the past 3 years, the share price has lost roughly two-thirds of its value and so far 2019 has seen further decline. Technical argument Limited: it’s no easy task trying to evaluate identify trading opportunities in price trends and patterns seen in small market capitalisation biotechnology. TTOO stock price is volatile because it is in possession of a breakthrough technology with its success relying on pivotal data that has not yet been made public. In addition, concerns remain, including cash burn and near-term financing. Even if TTOO is successful in achieving approval for various products the company may have difficulty getting hospitals and labs to adopt the technology. I have included indictors such as MACD, momentum, Moving Average MA, Relative Strength Index RSI and Point of Control POC. The conclusions from these indicators are limited, I have explained each individually on the graph. What I do draw from the graph is that TTOO has fallen back into the Point of Control: price point with the highest trade volume. We can see a bullish RSI divergence: TTOO makes a lower low and RSI forms a higher low and volume has started to increase. If investors consider the stock to be oversold the volume with continue to increase as traders buy stock and we will see a price rise. I would NOT buy stock based on this analysis because the volume spike could be investors offloading stock, even if we are at an all-time low. So let’s ignore the technical analysis because in this situation making an investment decision based solely on evaluating price trends won’t have any bearing on the outcome of upcoming catalysts and therefore the stocks potential value. Upcoming catalysts The company is in possession of a breakthrough technology for the detection of sepsis. A possible near-term catalyst for upside is results of the T2Bacteria Panel pivotal FDA clinical trial to be published in a peer-reviewed medical journal in Q2 2019 T2Lyme Panel is currently in a pivotal Phase 3 trial with very encouraging results so far and a $700 million market being targeted.
TLong
by warrenhochfeld
EURGBP BUY OPPORTUNITY. EVENT TRADING - BoEBank of England (BoE) meeting minutes 12:00 UTC today (2nd August) Two Catalysts for EUR/GBP 1) BoE will announce its interest rate decision at 14:00 UTC+2 on 2nd of August. Markets are pricing 80-90% implied probability of a rate hike to 0.75% (it is 0.5% now). From reported economic indicators, the unemployment rate remains glued at 4.25% and wage growth has decelerated compared to latest inflation report from May ( from 2.9% to 2.7%). Core inflation has also surprised to the downside. Calculating using the futures contracts, markets have priced in the rate hike, therefore there should not be a gap up if they hike. In that case the market would react more on BoE outlook of the economy and economic projections, and there is a chance they will not be as good as markets may expect, as expectations right now are really high, Which gives me grounds to believe that even with a rate hike there is bigger change of a gap up of EUR/GBP (weak GBP) than gap down. And if they surprisingly do not hike, then than would be a hell gap up omg that would be awesome.. :D 2) You can also see that EUR/GBP is on the up trend and is approaching lower trend line, which is a huge support for this pair. That means that there is a technical catalyst for EUR/GBP to go up.
Long
by laurynas.lucka
1